After finishing at $4.00 in the prior trading day, Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed at $3.94, down -1.50%. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 1070829 shares were traded.
Ratios:
Our goal is to gain a better understanding of AVIR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.24 and its Current Ratio is at 18.24. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 06, 2022, Morgan Stanley Downgraded its rating to Underweight which previously was Equal-Weight and also lowered its target price recommendation from $14 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 01 ’24 when Sommadossi Jean-Pierre sold 56,910 shares for $3.85 per share. The transaction valued at 218,819 led to the insider holds 116,557 shares of the business.
Horga Maria Arantxa sold 15,870 shares of AVIR for $60,963 on Feb 01 ’24. The Chief Medical Officer now owns 25,664 shares after completing the transaction at $3.84 per share. On Feb 01 ’24, another insider, Corcoran Andrea, who serves as the insider of the company, sold 15,843 shares for $3.84 each. As a result, the insider received 60,915 and left with 670,208 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 336.66M and an Enterprise Value of -239.05M.
Stock Price History:
Over the past 52 weeks, AVIR has reached a high of $5.19, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is 3.9690, while the 200-Day Moving Average is calculated to be 3.4885.
Shares Statistics:
The stock has traded on average 460.01K shares per day over the past 3-months and 363.67k shares per day over the last 10 days, according to various share statistics. A total of 83.44M shares are outstanding, with a floating share count of 73.79M. Insiders hold about 12.33% of the company’s shares, while institutions hold 64.13% stake in the company. Shares short for AVIR as of Feb 29, 2024 were 1.65M with a Short Ratio of 3.58, compared to 3.8M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.96% and a Short% of Float of 2.54%.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.61 for the current quarter, with a high estimate of -$0.57 and a low estimate of -$0.63, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.62 and low estimates of -$0.75.
Analysts are recommending an EPS of between -$2.5 and -$3.03 for the fiscal current year, implying an average EPS of -$2.76. EPS for the following year is -$2.92, with 3 analysts recommending between -$2.5 and -$3.14.
